During a retroactive review of distributor incident files, conducted as a capa in response to a recent fda inspection, a reportable adverse event was discovered.The patient reportedly developed a skin irritation which led to a welt under the therapy electrodes.The patient reported that she believed she was allergic to the metal in the therapy electrodes.Follow up indicated that the irritation improved with a prescription hydrocortisone cream and instructions from her physician to remove the lifevest for a day.The patient also indicated that she found out she was allergic to the snap on the garment.
|